MENU
MAZE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Maze Therapeutics (MAZE) Earnings Date & Reports
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity... Show more
A.I. Advisor
published Earnings
MAZE is expected to report earnings to fall 25.00% to -56 cents per share on November 05
Q3'26
Est.
$-0.57
Q2'26
Missed
by $0.19
Q1'26
Beat
by $0.13
Q4'25
Missed
by $0.02
Q3'25
Missed
by $0.04
The last earnings report on August 11 showed earnings per share of -75 cents, missing the estimate of -56 cents. With 71.14K shares outstanding, the current market capitalization sits at 1.49B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
171 Oyster Point boulevard
Phone
+1 650 850-5070
Employees
141
Web
https://www.mazetx.com